American Diabetes Association
Browse
DOCUMENT
DB23-0506_Online_Supplementary_Materials_Methods_Clean_Copy.pdf (91.14 kB)
DOCUMENT
DB23-0506_Online_Supplementary_Materials_Figure_Legends_Clean_Copy.pdf (65.66 kB)
IMAGE
SupplementaryFigure1.tif (4.33 MB)
IMAGE
SupplementaryFigure2.tif (3.96 MB)
DATASET
Online_Supplementary_Materials_Table_1.xlsx (41.92 kB)
1/0
5 files

KD025 is a casein kinase 2 inhibitor that protects against glucolipotoxicity in beta cells

figure
posted on 2024-01-11, 23:12 authored by Ranjan Devkota, Jonnell C. Small, Kaycee Carbone, Michael A. Glass, Amedeo Vetere, Bridget K. Wagner

Glucolipotoxicity (GLT), in which elevated levels of glucose and fatty acids have deleterious effects on β-cell biology, is thought to be one of the major contributors in progression of type 2 diabetes. In search of novel small molecules that protects β-cells against GLT, we previously discovered KD025, an inhibitor of Rho-associated coiled-coil containing kinase isoform 2 (ROCK2), as a GLT-protective compound in INS-1E cells and dissociated human islets. To further understand the mechanism of action of KD025, we found that pharmacological and genetic inhibition of ROCK2 was not responsible for the protective effects of KD025 against GLT. Instead, kinase profiling revealed that KD025 potently inhibits catalytic subunits of casein kinase 2 (CK2), a constitutively active serine/threonine kinase. We experimentally verified that the inhibition of one of the catalytic subunits of casein kinase 2, CK2A1, but not CK2A2, improved cell viability when challenged with GLT. We conclude that KD025 inhibits CK2 to protect β-cells from glucolipotoxicity.

Funding

This work was supported by the NIH Human Islet Research Network (HIRN; U01DK123717, B.K.W.). R.D. was supported by Knut and Alice Wallenberg Foundation, Sweden (KAW 2019.0580). The authors gratefully acknowledge the use of the Opera Phenix High-Content/High-Throughput imaging system at the Broad Institute, funded by the S10 Grant NIH OD-026839-01 (B.K.W.)

History

Usage metrics

    Diabetes

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC